Right - one problem, if he happens to be an investor in mnkd his testimony, though objectively valid as it is captivating, would be unhelpful and easily skewed in favor of the hijacked narrative that the short side uses to their advantage.
30pct? - I'm paid 40pct for the last three weeks.
Was there a change for you recently?
I rarely post anymore but...
I am sure it has crossed nearly EVERYBODY'S mind who has any interest in the potential long term prosperity or failure of this novel, second to market medication.
Inhalation therapy is on its own - just that.
I am 99.99999 pct confident that children(the future) when given a choice between taking a meal time pen #$%$ or a deep breath will OVERWHELMINGLY choose the breath.
I also happen to know the data pfe obtained in their initial pediatric studies before pulling exhubra from market.
This data is quite meaningful and has NEVER once been cited from my recollection.
STRONGEST BUY EVER.
Sentiment: Strong Buy